Pine River Capital Management’s Quest Diagnostics DGX Stock Holding History

Pine River Capital Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-5,600	Closed	-$515K	–	197
2016 Q4	$515K	Buy	+5,600	New	+$483K	0.02%	280
2016 Q2	–	Sell	-3,171	Closed	-$227K	–	452
2016 Q1	$227K	Sell	3,171 -622	-16%	-$41.7K	﹤0.01%	611
2015 Q4	$270K	Sell	3,793 -4,360	-53%	-$293K	﹤0.01%	609
2015 Q3	$501K	Buy	8,153 +1,153	+16%	+$80.6K	0.01%	521
2015 Q2	$508K	Buy	+7,000	New	+$517K	0.01%	504
2014 Q4	–	Sell	-8,400	Closed	-$510K	–	766
2014 Q3	$510K	Buy	+8,400	New	+$518K	0.01%	758

Other funds holding DGX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Pine River Capital Management's DGX Position: Q1 2017 in Review

Pine River Capital Management sold out of Quest Diagnostics (DGX) in Q1 2017, closing a stake of 5,600 shares — an estimated $515K sold.

Pine River Capital Management first reported a position in DGX in Q3 2014 and held it in 6 quarters. The position peaked at $515K in Q4 2016. 614 funds tracked by Wall St. Rank hold DGX as of Q1 2017.

Pine River Capital Management reported no remaining Quest Diagnostics position as of Q1 2017 after selling out during the quarter.
Pine River Capital Management sold 5,600 Quest Diagnostics shares in Q1 2017, an estimated $515K.
Pine River Capital Management first reported a position in Quest Diagnostics in Q3 2014 and held it in 6 quarters.
Pine River Capital Management's Quest Diagnostics position peaked at $515K in Q4 2016.
614 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2017.

Based on Pine River Capital Management's 13F filing for Q1 2017, filed 15 May 2017.